Andon Health (002432) Fundamentals 2026 — P/E 15.1x, Revenue Analysis | SniperIQ
Andon Health (002432) is a CN-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥38.0B, trading at ¥81.64 on the SHZ. This SniperIQ fundamentals page covers Andon Health's valuation (P/E 15.1x, P/B 1.6x), profitability (net margin 197.7%), revenue (¥1.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Andon Health's market cap?
Andon Health (002432) has a market capitalization of approximately ¥38.0B, trading at ¥81.64 on the SHZ. Market cap moves with the live share price.
What is Andon Health's P/E ratio?
Andon Health's trailing twelve-month P/E ratio is 15.1x, with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Andon Health?
Andon Health runs a net profit margin of 197.7%, a gross margin of 62.3%, and an operating margin of 226.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Andon Health generate?
Andon Health reported revenue of ¥1.4B for fiscal year 2025, with net income of ¥2.3B and earnings per share (EPS) of 5.23. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Andon Health pay a dividend?
Andon Health offers a trailing dividend yield of about 2.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Andon Health financially healthy?
Andon Health carries a debt-to-equity ratio of 0.30x and a current ratio of 2.93x, with a market beta of -0.60. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Andon Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Andon Health (002432) the key facts are: market cap ¥38.0B, P/E 15.1x, revenue ¥1.4B, 52-week range 37.69-94.94. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Andon Health's full fundamentals live
Get Andon Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.